Scope each area
We set a defined scope for each area, starting with safety, immunogenicity and immune response.
A global biopharmaceutical company wanted next-generation drug delivery vehicles. We landscaped four focus areas, from safety and immune response to nuclear targeting and endosomal escape, and tested hypotheses with experts.
The client is a global biopharmaceutical company. It wanted better delivery vehicles for its therapies.
Prescouter was asked to identify next-generation delivery vehicles for the client’s therapies across four areas: safety and immune response, nuclear localization and targeting, endosomal escape, and particle targeting.
Lower immunogenicity and inflammation.
Getting payloads to the nucleus.
Freeing payloads inside the cell.
We set a defined scope for each area, starting with safety, immunogenicity and immune response.
Our analysts searched the research for early-stage delivery technologies in each focus area.
Interviews with subject matter experts tested the most promising directions where needed.
Prescouter evaluated 27 early-stage drug delivery technologies that advance nuclear localization and targeting or evade recognition and clearance by the innate immune system. The client gained clear insight into the delivery landscape and new approaches to strengthen its market reach.
Early-stage delivery vehicles.
Approaches that reach the nucleus.
Avoiding innate immune clearance.
Delivery often decides whether a promising therapy reaches patients. Scanning early-stage science reveals options before they become crowded.
Scope the problem, scan the science and test the most promising options. Wherever you’re starting from, we’ll help you get there.
Or email [email protected]Pick a time on our calendar right now.
If you’d like to know the outcome of your submission, please leave your email address